Kevin Kalinsky, MD, assistant professor of medicine at the NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, has been awarded the One Race One Mission-Physician of Impact Award by Komen Greater NYC, for his dedication to making advancements in therapeutic options for breast cancer patients.
For Dr. Kalinsky, the aim has always been to offer excellent care to patients. “I was very honored to receive this award,” he says. “Komen has been instrumental in the tremendous strides we have made in breast cancer. We share their strong mission of not only preventing breast cancer but also having a day when no one gets sick or dies from the disease.”
A member of Columbia’s Herbert Irving Comprehensive Cancer Center (HICCC), Dr. Kalinsky has an active research program in various stages of breast cancer and is focusing on identifying novel treatments for the disease, including investigating advances in immunotherapy and antibody drug conjugates. He is particularly interested in triple negative breast cancer, a subset that is highly difficult to treat.
“Dr. Kalinsky was selected for his participation as an investigator in truly groundbreaking studies, and his kindness to and compassion for his patients,” says Linda Tantawi, chief executive of Komen NYC. “We share a commitment to patients with advanced disease to extend and improve quality of life.”
Komen Greater NYC will present Dr. Kalinsky with the inaugural award at the Sept. 9 Komen NYC Race for the Cure. A participant of Komen races in the past, Dr. Kalinsky plans to run again this September with a group from Columbia-NYP.
-Melanie A. Farmer